Treatment analysis and pharmaceutical care for one child with bacterial meningitis
10.12206/j.issn.1006-0111.202012022
- VernacularTitle:1例儿童细菌性脑膜炎的治疗分析与药学监护
- Author:
Ting LIU
1
;
Zhongqiang CAO
1
;
Min ZHAN
1
;
Zhou ZHANG
1
;
Yue WU
1
;
Xuejuan LI
1
;
Zebin CHEN
1
Author Information
1. Shenzhen children's hospital, Shenzhen 518038, China.
- Keywords:
bacterial meningitis;
anti-infection;
therapeutic drug monitoring;
pharmaceutical care;
children
- From:
Journal of Pharmaceutical Practice
2021;39(2):174-177
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the strategies of drug treatment and pharmaceutical care for children with bacterial meningitis. Methods The anti-infective therapy, therapeutic drug monitoring and dose adjustment of vancomycin in children with bacterial meningitis were analyzed and discussed according to relevant guidelines and literatures. Results Clinical pharmacists analyzed therapeutic regimen. According to the results of etiology and drug sensitivity, meropenem was discontinued and rifampicin was added. Based on drug monitoring of vancomycin, it is suggested to extend the infusion time of vancomycin to reach the target concentration. The child was discharged from hospital. Conclusion Recommendations of the relevant drug treatment guidelines and the latest medical research evidence should be provided by clinical pharmacists in order to promote reasonable and effective clinical uses of medicine.
